These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31187092)

  • 1. SLC41A1 and TRPM7 in magnesium homeostasis and genetic risk for Parkinson's disease.
    Sturgeon M; Wu P; Cornell R
    J Neurol Neuromedicine; 2016; 1(9):23-28. PubMed ID: 31187092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variability at the PARK16 locus.
    Tucci A; Nalls MA; Houlden H; Revesz T; Singleton AB; Wood NW; Hardy J; Paisán-Ruiz C
    Eur J Hum Genet; 2010 Dec; 18(12):1356-9. PubMed ID: 20683486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of magnesium transporter SLC41A1 in the striatum of 6-hydroxydopamine-induced parkinsonian rats.
    Lin L; Yan M; Wu B; Lin R; Zheng Z
    Brain Res Bull; 2018 Sep; 142():338-343. PubMed ID: 30172737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution p.A350V in Na⁺/Mg²⁺ exchanger SLC41A1, potentially associated with Parkinson's disease, is a gain-of-function mutation.
    Kolisek M; Sponder G; Mastrototaro L; Smorodchenko A; Launay P; Vormann J; Schweigel-Röntgen M
    PLoS One; 2013; 8(8):e71096. PubMed ID: 23976986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroprotective potential of magnesium in Parkinson's disease.
    Ray S
    Magnes Res; 2024 Jun; 36(4):69-81. PubMed ID: 38953416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant R244H in Na+/Mg2+ exchanger SLC41A1 in Taiwanese Parkinson's disease is associated with loss of Mg2+ efflux function.
    Lin CH; Wu YR; Chen WL; Wang HC; Lee CM; Lee-Chen GJ; Chen CM
    Parkinsonism Relat Disord; 2014 Jun; 20(6):600-3. PubMed ID: 24661466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPM7, the Mg(2+) inhibited channel and kinase.
    Bates-Withers C; Sah R; Clapham DE
    Adv Exp Med Biol; 2011; 704():173-83. PubMed ID: 21290295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNPs rs11240569, rs708727, and rs823156 in
    Cibulka M; Brodnanova M; Grendar M; Grofik M; Kurca E; Pilchova I; Osina O; Tatarkova Z; Dobrota D; Kolisek M
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione
    Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M
    Front Neurol; 2018; 9():222. PubMed ID: 29681884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models.
    Evsyukov V; Domanskyi A; Bierhoff H; Gispert S; Mustafa R; Schlaudraff F; Liss B; Parlato R
    Dis Model Mech; 2017 May; 10(5):633-643. PubMed ID: 28360124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral magnesium supplementation on the transcription of TRPM6, TRPM7, and SLC41A1 in individuals newly diagnosed of pre-hypertension. A randomized, double-blind, placebo-controlled trial.
    Rodríguez-Ramírez M; Rodríguez-Morán M; Reyes-Romero MA; Guerrero-Romero F
    Magnes Res; 2017 Aug; 30(3):80-87. PubMed ID: 29256407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.
    Zhao F; Wang W; Wang C; Siedlak SL; Fujioka H; Tang B; Zhu X
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1359-1370. PubMed ID: 28215578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the putative goldfish (Carassius auratus) magnesium transporter SLC41a1 and functional regulation in the gill, kidney, and intestine in response to dietary and environmental manipulations.
    Kodzhahinchev V; Kovacevic D; Bucking C
    Comp Biochem Physiol A Mol Integr Physiol; 2017 Apr; 206():69-81. PubMed ID: 28130070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interplay between TRPM7 and MagT1 in Maintaining Endothelial Magnesium Homeostasis.
    Castiglioni S; Locatelli L; Fedele G; Cazzaniga A; Malucelli E; Iotti S; Maier JA
    Membranes (Basel); 2023 Feb; 13(3):. PubMed ID: 36984673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
    Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
    Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.